Tumor Budding and E-Cadherin Expression Are Useful Predictors of Nodal Involvement in T1 Esophageal Squamous Cell Carcinoma

被引:5
|
作者
Nakagawa, Yasuo [1 ]
Ohira, Masaichi [1 ]
Kubo, Naoshi [1 ]
Yamashita, Yoshito [2 ]
Sakurai, Katsunobu [1 ]
Toyokawa, Takahiro [1 ]
Tanaka, Hiroaki [1 ]
Muguruma, Kazuya [1 ]
Shibutani, Masatsune [1 ]
Yamazoe, Sadaaki [1 ]
Kimura, Kenjiro [1 ]
Nagahara, Hisashi [1 ]
Amano, Ryosuke [1 ]
Ohtani, Hiroshi [1 ]
Yashiro, Masakazu [1 ]
Maeda, Kiyoshi [1 ]
Hirakawa, Kosei [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan
[2] Osaka City Gen Hosp, Dept Gastroenterol Surg, Osaka, Japan
关键词
T1 Esophageal cancer; tumor budding; E-cadherin; nodal metastasis; GROWTH-FACTOR C; CANCER; METASTASIS; PROGNOSIS; RESECTION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Endoscopic treatment has been increasingly used for T1 esophageal squamous cell carcinoma (ESCC). However, this therapy is sometimes incomplete if the depth of the T1 primary tumor reaches the muscularis mucosae or submucosal layer because these tumors have a relatively high incidence of lymph node metastasis. However, to our knowledge, no previous reports on the prediction of nodal metastasis determined by evaluating primary tumor specimens of patients with ESCC are available. Patients and Methods: A total of 55 patients with T1 ESCC invading as deep as the submucosal layer who underwent curative esophagectomy were examined. We investigated the significance of the immunohistochemical staining of Vascular endothelial growth factor-C (VEGF-C) and E-cadherin in the primary tumor and Tumor budding for prediction of nodal metastasis. Results: Metastasis to the regional lymph nodes was observed in 26 cases (47.3%) in this setting. VEGF-C expression and reduced E-Cadherin expression in the primary tumor was observed in 32 (58.1%) and 38 cases (69.1%), respectively. High-grade tumor budding was observed in 29 cases (52.7%). E-cadherin expression and tumor budding were closely correlated with nodal metastasis (p=0.04 and <0.01 respectively), whereas VEGF-C expression tended to correlate with lymph node metastasis (p=0.06). In addition, high-grade tumor budding was significantly correlated (p<0.01) with reduced E-cadherin expression. The accuracy of tumor budding and E-cadherin expression for nodal metastasis were 67.3% and 65.4% respectively, comparable with the one of lymphatic involvement (63%). Tumor budding (p<0.01), but not E-cadherin and VEGF-C expression, was significantly correlated with poor survival. Conclusion: After the endoscopic treatment, additional therapy, such as surgery or chemoradiotherapy, may be required if reduced E-cadherin expression and high-grade tumor budding are observed in primary tumor specimen.
引用
收藏
页码:5023 / 5029
页数:7
相关论文
共 50 条
  • [31] MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
    Song, Ye
    Li, Jiangchao
    Zhu, Yinghui
    Dai, Yongdong
    Zeng, Tingting
    Liu, Lulu
    Li, Jianbiao
    Wang, Hongbo
    Qin, Yanru
    Zeng, Musheng
    Guan, Xin-Yuan
    Li, Yan
    ONCOTARGET, 2014, 5 (22) : 11669 - 11680
  • [32] Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma
    Chung, Y.
    Law, S.
    Kwong, D. L. W.
    Luk, J. M.
    DISEASES OF THE ESOPHAGUS, 2011, 24 (01) : 49 - 55
  • [33] α-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma
    Setoyama, Tetsuro
    Natsugoe, Shoji
    Okumura, Hiroshi
    Matsumoto, Masataka
    Uchikado, Yasuto
    Yokomakura, Naoya
    Ishigami, Sumiya
    Aikou, Takashi
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (02) : 148 - 155
  • [34] Aberrant expression of MYH9 and E-cadherin in esophageal squamous cell carcinoma and their relationship to vasculogenic mimicry
    Cheng, Lili
    Tao, Xiaoying
    Qin, Yanzi
    Wang, Jingping
    Xu, Jing
    Ci, Hongfei
    Wu, Qiong
    Zheng, Dafang
    Wang, Qi
    Cheng, Zenong
    Wu, Shiwu
    Tao, Yisheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (06): : 2205 - +
  • [35] Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma
    Zou, Jian
    Yang, Hui
    Chen, Fei
    Zhao, Houyu
    Lin, Pin
    Zhang, Jie
    Ye, Huiping
    Wang, Lihong
    Liu, Shixi
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2010, 19 (01) : 11 - 17
  • [36] Progression of Oral Squamous Cell Carcinoma Accompanied with Reduced E-Cadherin Expression but Not Cadherin Switch
    Hashimoto, Takashi
    Soeno, Yuichi
    Maeda, Genta
    Taya, Yuji
    Aoba, Takaaki
    Nasu, Masanori
    Kawashiri, Shuichi
    Imai, Kazushi
    PLOS ONE, 2012, 7 (10):
  • [37] An immunohistochemical study of E-Cadherin and snail expression in laryngeal squamous cell carcinoma
    Tanoglidi, A.
    Tsopanomichalou, M.
    Barbatis, C.
    Kostopoulos, C.
    Pantzartzi, O.
    Gorgoulis, V.
    VIRCHOWS ARCHIV, 2012, 461 : S23 - S24
  • [38] EXPRESSION OF E-CADHERIN WITH CORRELATION TO CLINICOPATHOLOGIC PARAMETERS IN ORAL SQUAMOUS CELL CARCINOMA
    Shin, Jae-Myoung
    Kim, Young-Sill
    Kim, Chang-Hyen
    Pyo, Sung-Woon
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2005, 31 (01) : 1 - 6
  • [39] E-cadherin and Par 3 expression in conjunctival melanoma and squamous cell carcinoma
    Schmidt, Rebecca
    Cursiefen, Claus
    Heindl, Ludwig M.
    Schlereth, Simona
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [40] Dynamic expression of E-cadherin regulates metastasis of oral squamous cell carcinoma
    Katsurano, Miki
    Ibaraki, Souichiro
    Sasaki, Akira
    Tsuji, Takanori
    Hu, Guo-Fu
    CANCER RESEARCH, 2006, 66 (08)